Earlier this year, the DEA responded to President Biden's directive to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act. This pivotal change, if finalized, would reclassify marijuana as a drug with moderate to low potential for dependence, strictly for medical use.  Chapters 

Introduction to Workplace Issues and Cannabis Rescheduling 05:06 Understanding the Rescheduling Process of Cannabis 09:48 Implications of Rescheduling for Employers 15:07 Legal Challenges and Considerations for Healthcare Employers 19:50 Navigating Drug Testing and Employee Policies 24:51 Conclusion and Future Considerations

We get AI for work: Tackling the Challenges of Diverse AI Systems

In the face of evolving challenges in labor and employment law, Jackson Lewis attorneys identify issues dominating the modern workplace and answer the question on every employer's mind – how will my business be impacted? Stream episodes of our podcast program on the platform of your choosing.